| abstract |
The present invention describes methods to inhibit the replication of influenza viruses in a biological or patient sample, to reduce the amount of influenza viruses in a biological or patient sample and to treat influenza in a patient; The methods comprise the step of administering to the biological or patient sample an effective amount of a compound represented by the structural Formula (I): SEE FORMULA (I), or a pharmaceutically acceptable salt thereof, wherein the values of the structural Formula (I) are as described in the present description. A compound is represented by the structural Formula (I) or a pharmaceutically acceptable salt thereof, wherein the values of the Structural Formula (I) are as described in the present description. A pharmaceutical composition comprises an effective amount of the pharmaceutically acceptable compound or salt thereof and a pharmaceutically acceptable carrier, adjuvant or carrier. |